(Q39945220)

15 September 2017

A sugar-modified phosphole gold complex with antiproliferative properties acting as a thioredoxin reductase inhibitor in MCF-7 cells (English)

1 reference

Elisabeth Davioud-Charvet

15 September 2017

6

1 reference

15 September 2017

5

Régis Réau

0 references

Valérie Deborde

3

object named as

Valérie Deborde

0 references

Elodie Viry

1

object named as

Elodie Viry

0 references

Denyse Bagrel

7

object named as

Denyse Bagrel

0 references

author name string

Eric Battaglia

2

1 reference

PubMed ID

18759235

15 September 2017

Tobias Müller

4

1 reference

15 September 2017

1 November 2008

1 reference

15 September 2017

1 reference

15 September 2017

3

1 reference

15 September 2017

11

1 reference

15 September 2017

1667-1670

1 reference

The thioredoxin system—From science to clinic

15 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800210

7 January 2021

Reactive oxygen species, antioxidants, and the mammalian thioredoxin system

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800210

7 January 2021

The thioredoxin reductase/thioredoxin system: novel redox targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800210

7 January 2021

Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800210

7 January 2021

On the potential of thioredoxin reductase inhibitors for cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800210

7 January 2021

Undressing of phosphine gold(I) complexes as irreversible inhibitors of human disulfide reductases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800210

7 January 2021

Phosphole-containing pi-conjugated systems: from model molecules to polymer films on electrodes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800210

7 January 2021

Correlation of the in vitro cytotoxic and in vivo antitumor activities of gold(I) coordination complexes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800210

7 January 2021

Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800210

7 January 2021

Mechanistic studies on a novel, highly potent gold-phosphole inhibitor of human glutathione reductase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800210

7 January 2021

Intestinal uptake and metabolism of auranofin, a new oral gold-based antiarthritis drug

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800210

7 January 2021

The cellular pharmacology of auranofin

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800210

7 January 2021

Metal compounds in therapy and diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800210

7 January 2021

Mitochondrial thioredoxin reductase and thiol status

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800210

7 January 2021

Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800210

7 January 2021

Auranofin induces apoptosis and when combined with retinoic acid enhances differentiation of acute promyelocytic leukaemia cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800210

7 January 2021

Mitochondria are primary targets in apoptosis induced by the mixed phosphine gold species chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I) in melanoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800210

7 January 2021

A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: implications for anticancer therapeutics targeted to mitochondria.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800210

7 January 2021

Human placenta thioredoxin reductase: preparation and inhibitor studies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800210

7 January 2021

New thiophene analogues of kenpaullone: synthesis and biological evaluation in breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800210

7 January 2021

Identifiers

DOI

10.1002/CMDC.200800210

1 reference

15 September 2017

1 reference

PubMed ID

18759235